Concord Wealth Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$135 Buy
+10
New +$120 ﹤0.01% 858
2026
Q1
Sell
-13
Closed -$93 607
2025
Q4
$93 Hold
13
﹤0.01% 823
2025
Q3
$139 Hold
13
﹤0.01% 802
2025
Q2
$126 Sell
13
-7
-35% -$72 ﹤0.01% 828
2025
Q1
$298 Hold
20
﹤0.01% 774
2024
Q4
$298 Sell
20
-1,015
-98% -$16.5K ﹤0.01% 887
2024
Q3
$19.8K Sell
1,035
-35
-3% -$725 ﹤0.01% 471
2024
Q2
$22.1K Sell
1,070
-8
-0.7% -$159 ﹤0.01% 412
2024
Q1
$20.3K Sell
1,078
-34
-3% -$583 ﹤0.01% 484
2023
Q4
$16K Buy
1,112
+2
+0.2% +$27 ﹤0.01% 508
2023
Q3
$19.3K Buy
1,110
+1,001
+918% +$20.9K ﹤0.01% 513
2023
Q2
$2.27K Sell
109
-1,106
-91% -$24K ﹤0.01% 847
2023
Q1
$28.6K Sell
1,215
-68
-5% -$1.83K 0.01% 431
2022
Q4
$35.8K Buy
+1,283
New +$32.8K 0.01% 427
2022
Q3
Sell
-1,466
Closed -$49K 808
2022
Q2
$49K Buy
+1,466
New +$51.3K 0.01% 385
2022
Q1
Sell
-1,301
Closed -$40K 1351
2021
Q4
$40K Buy
1,301
+1,243
+2,143% +$40.5K 0.01% 492
2021
Q3
$2K Sell
58
-21
-27% -$672 ﹤0.01% 769
2021
Q2
$2K Buy
+79
New +$2.6K ﹤0.01% 907

Other funds holding OGN

Concord Wealth Partners's OGN Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Organon & Co (OGN) in Q2 2026: 10 shares worth $135. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in OGN as recently as Q4 2025.

Concord Wealth Partners first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $49K in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Concord Wealth Partners held 10 shares of Organon & Co worth $135 as of Q2 2026.
  • Organon & Co was a new Concord Wealth Partners position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #858 holding.
  • Concord Wealth Partners first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
  • Concord Wealth Partners's Organon & Co position peaked at $49K in Q2 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.